Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup

Aurore Touzart(Inserm), Vahid Asnafi(Hôpital Necker-Enfants Malades)

Science Translational Medicine

May 26, 2021

10.1126/scitranslmed.abc4834

Cited by 41

Related Papers

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

|Journal of Clinical Investigation|2008|1.8k

The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery

|Cell|2016|563

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

|Blood|2009|269

PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL

|Blood|2021|36

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i> -Mutant Clonal Hematopoiesis

|Blood Cancer Discovery|2023|33